Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan.

International journal of molecular sciences - 24 Jun 2022

Luo Yung-Hung, Liang Kung-Hao, Huang Hsu-Ching, Shen Chia-I, Chiang Chi-Lu, Wang Mong-Lien, Chiou Shih-Hwa, Chen Yuh-Min

Abstract excerpt

Lung cancers are life-threatening malignancies that cause great healthcare burdens in Taiwan and worldwide. The 5-year survival rate for Taiwanese patients with lung cancer is approximately 29%, an unsatisfactorily low number that remains to be improved. We first reviewed the molecular epidemiology derived from a deep proteogenomic resource in Taiwan. The nuclear factor erythroid 2-related factor 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to NF-E2-Related Factor 2

Share to Phosphatidylinositol 3-Kinases

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins c-akt

Share to Taiwan

Source

Open in PubMed Open full text

Identifiers

PMID: 35806042
DOI: 10.3390/ijms23137037
PMCID: PMC9266727

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan.PMID 35806042Read ↗

Lung cancer and metastasis: new opportunities and challenges.Semantic proximity Read ↗

The Current Roadmap of Lung Cancer Biology, Genomics and Racial DisparitySemantic proximity Read ↗

Catalog of Lung Cancer Gene Mutations Among Chinese PatientsSemantic proximity Read ↗

Comprehensive Network Analysis of Different Subtypes of Molecular Disorders in Lung CancerSemantic proximity Read ↗

Clinical trials and biomarker research on lung cancer in China.Semantic proximity Read ↗

Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.Semantic proximity Read ↗

Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma.Semantic proximity Read ↗

Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance.Semantic proximity Read ↗

Novel molecular subtype-based precision therapy improves prognosis for lung adenocarcinoma patientsSemantic proximity Read ↗

Evolving trends in lung cancer: Epidemiology, diagnosis, and management.Semantic proximity Read ↗

Construction of a Prognostic Model in Lung Adenocarcinoma Based on Ferroptosis-Related GenesSemantic proximity Read ↗

Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.